(Q43277935)

18 November 2017

title

Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis (English)

1 reference

18 November 2017

0 references

11

Michael Trauner

1 reference

18 November 2017

Micha Loebermann

1

1 reference

18 November 2017

Martina Sombetzki

2

1 reference

18 November 2017

Cord Langner

3

1 reference

18 November 2017

Andrea Fuchsbichler

4

1 reference

18 November 2017

Judith Gumhold

5

1 reference

18 November 2017

Dagmar Silbert

6

1 reference

18 November 2017

Diana Riebold

7

1 reference

18 November 2017

Martha Holtfreter

8

1 reference

18 November 2017

Peter Fickert

9

1 reference

18 November 2017

Horst Nizze

10

1 reference

18 November 2017

Emil C Reisinger

12

1 reference

18 November 2017

publication date

11 September 2009

1 reference

Tropical Medicine and International Health

18 November 2017

published in

1 reference

18 November 2017

volume

14

1 reference

18 November 2017

issue

11

1 reference

18 November 2017

page(s)

1418-1425

1 reference

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

The global status of schistosomiasis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Significance of bile-duct changes in schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Ursodeoxycholic acid treatment of vanishing bile duct syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Inhibition of Liver Fibrosis by L-Azetidine-2-Carboxylic Acid in Rats Treated with Carbon Tetrachloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Hepatic fibrosis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

Immunopathogenesis of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02387.X

10.1111/J.1365-3156.2009.02387.X

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference